The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PM, TGTX, ABBV, HTHT and SFIX

NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) — The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        

Philip Morris International, Inc.  (NYSE: PM)
Class Period: July 26, 2016 to April 18, 2018
Lead Plaintiff Deadline: November 5, 2018

The lawsuit alleges Philip Morris International, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Philip Morris was experiencing a faster decline in overall cigarette and e-cigarette (or “heated tobacco”) sales volumes during the first quarter of 2018 than investors had been led to believe; (2) Philip Morris’ much-lauded sales initiatives had stalled; (3) Philip Morris was experiencing adverse sales headwinds in key markets; and (4) as a result of the foregoing, defendants’ statements about Philip Morris’ business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.

Get additional information about the PM lawsuit: http://www.kleinstocklaw.com/pslra-1/philip-morris-international-inc-loss-submission-form?wire=3

TG Therapeutics, Inc. (NASDAQCM: TGTX)
Class Period: June 4, 2018 to September 25, 2018
Lead Plaintiff Deadline: December 3, 2018

The complaint alleges that during the class period TG Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) TG was involved in cleaning the data collected in the UNITY-CLL Trial; and as a result, was able to gain an understanding as to the efficacy of the combination therapy; (2) as a result of that data cleaning, TG knew the UNITY-CLL Trial had failed to meet its stated goal and as a result, the Company would not be able to seek accelerated approval; and (3) given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival.

Get additional information about the TGTX lawsuit: http://www.kleinstocklaw.com/pslra-1/tg-therapeutics-inc-loss-submission-form?wire=3

AbbVie Inc. (NYSE: ABBV)
Class Period: October 25, 2013 to September 18, 2018
Lead Plaintiff Deadline: November 20, 2018

The complaint alleges that throughout the class period AbbVie Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) AbbVie’s strategy to increase the sales growth of its blockbuster drug, HUMIRA, relied in part upon illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would foreseeably lead to heightened scrutiny by State governments and agencies; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Get additional information about the ABBV lawsuit: http://www.kleinstocklaw.com/pslra-1/abbvie-inc-loss-submission-form?wire=3

Huazhu Group Limited (NASDAQ: HTHT)
Class Period: May 14, 2018 to August 28, 2018
Lead Plaintiff Deadline: December 7, 2018

The complaint alleges that during the class period Huazhu Group Limited made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate security measures to protect customer information; (2) as a result of the foregoing, the Company would be susceptible to increased litigation risk and higher expenses; (3) as a result of the foregoing, the Company’s goodwill would potentially suffer, leading to lower revenues; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Get additional information about the HTHT lawsuit: http://www.kleinstocklaw.com/pslra-1/huazhu-group-limited-loss-submission-form?wire=3

Stitch Fix, Inc. (NASDAQ: SFIX)
Class Period: June 8, 2018 to October 1, 2018
Lead Plaintiff Deadline: December 10, 2018

The lawsuit alleges that Stitch Fix, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Stitch Fix’s active client growth had slowed to a crawl; (2) Stitch Fix had completely shut down its television advertising campaign for 10 of the 13 weeks in fourth quarter 2018, dramatically decreasing the number of new active client additions; and (3) as a result, the Company’s current business metrics and financial prospects were not as strong as it had led the market to believe during the Class Period.

Get additional information about the SFIX lawsuit: http://www.kleinstocklaw.com/pslra-1/stitch-fix-inc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com